Three independent discounted-cash-flow-style models value Zimmer Biomet Holdings, Inc. every trading day. 1 of 3 currently price ZBH above its market price.
| Free Cash Flow model | $118.63 |
| Excess Profit model | $-46.96 |
| Residual Earnings model | $6.07 |
| Dividend Discount model | $29.73 |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +4.2% |
| Net debt / EBITDA | 6.6× |
| Gross margin | +69.7% |
| Revenue CAGR | +5.9% |
| Cash conversion | 2.4× |
| Dividend yield | +1.1% |
| Buyback yield | +2.5% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open ZBH in StockKitty